Published in Biotechnol Appl Biochem on September 16, 2013
Tumor imaging using a picomolar affinity HER2 binding affibody molecule. Cancer Res (2006) 2.46
Stabilization of a beta-hairpin in monomeric Alzheimer's amyloid-beta peptide inhibits amyloid formation. Proc Natl Acad Sci U S A (2008) 1.99
Affibody molecules for epidermal growth factor receptor targeting in vivo: aspects of dimerization and labeling chemistry. J Nucl Med (2009) 1.54
Display of proteins on bacteria. J Biotechnol (2002) 1.48
Directed evolution to low nanomolar affinity of a tumor-targeting epidermal growth factor receptor-binding affibody molecule. J Mol Biol (2008) 1.19
Epitope mapping of antibodies using bacterial surface display. Nat Methods (2008) 1.18
Biotechnological applications for surface-engineered bacteria. Biotechnol Appl Biochem (2004) 1.17
Affinity proteomics for systematic protein profiling of chromosome 21 gene products in human tissues. Mol Cell Proteomics (2003) 1.15
Non-immunoglobulin based protein scaffolds. Curr Opin Biotechnol (2011) 1.14
Genetic design for facilitated production and recovery of recombinant proteins in Escherichia coli. Biotechnol Appl Biochem (2002) 1.10
Selection and characterization of Affibody ligands binding to Alzheimer amyloid beta peptides. J Biotechnol (2006) 1.07
Cellular studies of binding, internalization and retention of a radiolabeled EGFR-binding affibody molecule. Nucl Med Biol (2007) 1.06
Sequestration of the Abeta peptide prevents toxicity and promotes degradation in vivo. PLoS Biol (2010) 1.05
In vitro characterization of a bivalent anti-HER-2 affibody with potential for radionuclide-based diagnostics. Cancer Biother Radiopharm (2005) 1.03
Affibody-mediated tumour targeting of HER-2 expressing xenografts in mice. Eur J Nucl Med Mol Imaging (2006) 1.02
Comparative in vivo evaluation of technetium and iodine labels on an anti-HER2 affibody for single-photon imaging of HER2 expression in tumors. J Nucl Med (2006) 0.99
Engineered affinity proteins--generation and applications. J Biotechnol (2009) 0.95
Engineered affinity proteins for tumour-targeting applications. Biotechnol Appl Biochem (2009) 0.95
Inhibiting HER3-mediated tumor cell growth with affibody molecules engineered to low picomolar affinity by position-directed error-prone PCR-like diversification. PLoS One (2013) 0.94
A novel affinity protein selection system based on staphylococcal cell surface display and flow cytometry. Protein Eng Des Sel (2008) 0.93
Exploring epitopes of antibodies toward the human tryptophanyl-tRNA synthetase. N Biotechnol (2009) 0.92
Engineering and characterization of a bispecific HER2 x EGFR-binding affibody molecule. Biotechnol Appl Biochem (2009) 0.92
Combining phage and staphylococcal surface display for generation of ErbB3-specific Affibody molecules. Protein Eng Des Sel (2010) 0.91
Cellular effects of HER3-specific affibody molecules. PLoS One (2012) 0.91
Fine affinity discrimination by normalized fluorescence activated cell sorting in staphylococcal surface display. FEMS Microbiol Lett (2005) 0.91
Generation of tumour-necrosis-factor-alpha-specific affibody molecules capable of blocking receptor binding in vitro. Biotechnol Appl Biochem (2009) 0.91
Molecular design and optimization of 99mTc-labeled recombinant affibody molecules improves their biodistribution and imaging properties. J Nucl Med (2011) 0.89
Generation and evaluation of bispecific affibody molecules for simultaneous targeting of EGFR and HER2. Bioconjug Chem (2012) 0.87
Evaluation of staphylococcal cell surface display and flow cytometry for postselectional characterization of affinity proteins in combinatorial protein engineering applications. Appl Environ Microbiol (2007) 0.86
Selection and characterization of an HIV-1 gp120-binding affibody ligand. Biotechnol Appl Biochem (2006) 0.85
Approaches for systematic proteome exploration. Biomol Eng (2007) 0.85
Vector engineering to improve a staphylococcal surface display system. FEMS Microbiol Lett (2002) 0.85
Evaluation of a HER2-targeting affibody molecule combining an N-terminal HEHEHE-tag with a GGGC chelator for 99mTc-labelling at the C terminus. Tumour Biol (2012) 0.85
Immunisation of mice against neosporosis with recombinant NcSRS2 iscoms. Vet Parasitol (2005) 0.84
Engineering of a bispecific affibody molecule towards HER2 and HER3 by addition of an albumin-binding domain allows for affinity purification and in vivo half-life extension. Biotechnol J (2014) 0.84
Surface display of a single-domain antibody library on Gram-positive bacteria. Cell Mol Life Sci (2012) 0.84
HER2-positive tumors imaged within 1 hour using a site-specifically 11C-labeled Sel-tagged affibody molecule. J Nucl Med (2012) 0.83
Enhancement of DNA vaccine potency by linkage of Plasmodium falciparum malarial antigen gene fused with a fragment of HSP70 gene. Vaccine (2005) 0.82
Engineering streptococcal protein G for increased alkaline stability. Protein Eng (2002) 0.81
An improved dual-expression concept, generating high-quality antibodies for proteomics research. Biotechnol Appl Biochem (2003) 0.80
Generation of Affibody ligands binding interleukin-2 receptor alpha/CD25. Biotechnol Appl Biochem (2008) 0.80
Imaging of HER3-expressing xenografts in mice using a (99m)Tc(CO) 3-HEHEHE-Z HER3:08699 affibody molecule. Eur J Nucl Med Mol Imaging (2014) 0.80
General strategies for efficient adjuvant incorporation of recombinant subunit immunogens. Vaccine (2005) 0.79
Epitope mapping using gram-positive surface display. Curr Protoc Immunol (2010) 0.79
Affibody-mediated transferrin depletion for proteomics applications. Biotechnol J (2007) 0.79
Engineering of staphylococcal surfaces for biotechnological applications. J Biotechnol (2002) 0.79
Immunogenicity and protective effect against murine cerebral neosporosis of recombinant NcSRS2 in different iscom formulations. Vaccine (2007) 0.78
Staphylococcal surface display in combinatorial protein engineering and epitope mapping of antibodies. Recent Pat Biotechnol (2010) 0.78
Construction and characterization of affibody-Fc chimeras produced in Escherichia coli. J Immunol Methods (2002) 0.78
Simplified characterization through site-specific protease-mediated release of affinity proteins selected by staphylococcal display. FEMS Microbiol Lett (2007) 0.78
A novel affinity gene fusion system allowing protein A-based recovery of non-immunoglobulin gene products. J Biotechnol (2002) 0.78
Staphylococcal display for combinatorial protein engineering of a head-to-tail affibody dimer binding the Alzheimer amyloid-β peptide. Biotechnol J (2012) 0.77
Affinity recovery of eight HER2-binding affibody variants using an anti-idiotypic affibody molecule as capture ligand. Protein Expr Purif (2010) 0.77
Fluorescence-activated cell sorting of specific affibody-displaying staphylococci. Appl Environ Microbiol (2003) 0.77
Achieving directed immunostimulating complexes incorporation. Expert Rev Vaccines (2006) 0.77
Order of amino acids in C-terminal cysteine-containing peptide-based chelators influences cellular processing and biodistribution of 99mTc-labeled recombinant Affibody molecules. Amino Acids (2011) 0.76
Applying biotin-streptavidin binding for iscom (immunostimulating complex) association of recombinant immunogens. Biotechnol Appl Biochem (2005) 0.75
General expression vectors for Staphylococcus carnosus enabled efficient production of the outer membrane protein A of Klebsiella pneumoniae. FEMS Microbiol Lett (2002) 0.75
A high-stringency proteomics concept aimed for generation of antibodies specific for cDNA-encoded proteins. Biotechnol Appl Biochem (2002) 0.75
Single-vector three-frame expression systems for affinity-tagged proteins. FEMS Microbiol Lett (2002) 0.75